Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / BSGM - Sorrento teams up with ViralClear to explore COVID-19 combo treatment

BSGM - Sorrento teams up with ViralClear to explore COVID-19 combo treatment

BioSig Technologies Inc.
Sorrento Therapeutics (SRNE) inks an agreement with ViralClear Pharmaceuticals, parent of BioSig Technologies (BSGM), aimed at exploring the potential of small molecule and antibody combination therapies in COVID-19.SRNE will initially contribute neutralizing antibody STI-1400 while ViralClear will contribute antiviral IMPDH inhibitor merimipodib (currently being tested in a mid-stage study with Gilead's remdesivir).The combo will be initially assessed in a Golden Syrian hamster model of COVID-19.SRNE is up 1% premarket on robust volume while BSGM is up 5% on light volume.

For further details see:

Sorrento teams up with ViralClear to explore COVID-19 combo treatment
Stock Information
Company Name: BioSig Technologies Inc.
Stock Symbol: BSGM
Market: NASDAQ
Website: biosig.com
Menu
BSGM BSGM Quote BSGM Short BSGM News BSGM Articles BSGM Message Board
Get BSGM Alerts

News, Short Squeeze, Breakout and More Instantly...